Literature DB >> 32762749

Burden of pelvic organ prolapse in Ethiopia: a systematic review and meta-analysis.

Getnet Gedefaw1,2, Asmamaw Demis3,4.   

Abstract

BACKGROUND: Pelvic organ prolapse can significantly affect a woman's quality of life by compromising physical, social, psychological and sexual function. Pelvic organ disorders and its consequences have higher economic burden to the patient as well to the country. Therefore, this systematic review and met- analysis aimed to estimate the burden of POP in Ethiopia.
METHODS: International databases (MEDLINE/Pub Med, Hinari, Scopus, Google scholar, African journals and literatures were searched and seven eligible cross sectional and two case control studies were included in this systematic review and meta-analysis. Eggers test and funnel plot were computed to check publication bias across the studies. Publication bias was computed using a funnel plot and eggers test. Heterogeneity of the studies was checked using Cochrane Q-test and I2 statistic. Subgroup analysis was computed for the evidence of heterogeneity.
RESULTS: This systematic review and meta-analysis revealed that the overall national prevalence of pelvic organ prolapse in Ethiopia was 23.52% (95% CI: 61.04, 80.24). Being rural resident (AOR = 3.29; 95% CI: 1.38-7.85), I2 = 47.5%, P = 0.167), having < 18.5 BMI (AOR = 2.59; 95% CI: 1.53-4.4), I2 = 59.9%, P = 0.64), and age > 40(AOR = 7.43; 95% CI: 2.27-24.29), I2 = 75.9%, P = 0.016) were the associated risk factors for pelvic organ prolapse.
CONCLUSIONS: The pooled prevalence of pelvic organ prolapse was high. Residence, body mass index and age of the women were the predictors of pelvic organ prolpase. Creating awareness and identifying the modifiable and non modifiable risk factors for pelvic organ prolpase is a crucial strategy to prevent further complications and risk of operation.

Entities:  

Keywords:  Meta-analysis; Pelvic floor disorders; Systematic review

Mesh:

Year:  2020        PMID: 32762749      PMCID: PMC7412834          DOI: 10.1186/s12905-020-01039-w

Source DB:  PubMed          Journal:  BMC Womens Health        ISSN: 1472-6874            Impact factor:   2.809


Background

Pelvic organ prolapse is a complex condition resulting from the weakness and defects of pelvic floor structures. Pelvic organ prolapse (POP) is the descent of one or more aspects of the vagina and uterus: the anterior vaginal wall, posterior vaginal wall, the uterus (cervix), or the apex of the vagina (vaginal vault or cuff scar after hysterectomy) [1]. Worldwide, millions of women have been affected by pelvic floor disorders. One in every nine American women will undergo surgery for a pelvic floor disorder in her lifetime, with 30% of women having a chance of requiring additional surgery for the same condition [2, 3]. Pelvic organ prolapse occurs when the pelvic floor no longer supports the proper positioning of the pelvic organs, i.e. the vagina, bladder, rectum or uterus. In unites states of America, around 6–7% of the women having pelvic floor disorders were experiencing pelvic and urinary symptoms. Feeling of vaginal bulging and/or pelvic pressure, urinary incontinence, and constipation has been identified as symptoms of pelvic organ prolapse [4-6]. In different countries, the number of admissions for POP surgery was significantly increasing; for instance, the rate of admission for POP surgery per 1000 women 0.87, 1.14, 1.13 in Germany, France, and England respectively [7]. The estimated prevalence of pelvic organ prolapse (POP) has been reported with a figure of nearly 9%, however, the burden of POP in low and middle income countries particularly in Sub Saharan African countries is still challenging. Moreover, the prevalence of POP in low income countries is much more increasing which recently has been reported to be around 20% [8, 9]. POP and its complications make an impact on a considerable economic burden on the affected person. About 11% of the American women undergo surgery for POP or incontinence before the age of 79, with 29.2% of the women having a chance of requiring additional surgery [10]. Pelvic organ prolapse is highly prevalent among women with the age of over 40 years old, geriatric women, and postmenopausal women with the estimated prevalence of 41–50% [11, 12]. As different studies, in low and middle income countries showed the mean of pelvic organ prolaps is 19.7% with the estimated range from 3.4 to 56.4%. Moreover, most studies were small and not population based, as a result methods of ascertaining of POP and definitions have been varied [9]. High parity, older age, obesity, pregnancy and vaginal delivery, menopause, constipation, persistent coughing, early age at first delivery, forceps delivery, prolonged second stage labor, and prolonged heavy lifting are the revealed contributing factors to cause strain to the pelvic floor. The global burden of Pelvic floor disorder is increasing due to increasing the age of the population [13]. The symptoms pelvic floor disorders had affect many aspects of a woman’s life, such as social, psychological, occupational, domestic, physical, cognitive, behavioral and sexual domains. In general, pelvic floor disorders have a negative impact on women’s lives, emotional and quality of life. Certainly, POP may be associated with a variety of systemic symptoms such as urinary, bowel and sexual symptoms which may significantly confrontation the quality of life of the women have been facing different mental and psychological illness such as mood and personal disorders [14, 15]. In Ethiopia, institutional delivery is limited, high fertility rates and higher rates of gynecologic disease have been reported and only 48% of women deliver in health institutions [16]. In Ethiopia, there is no any take apart strategy to prevent and manage pelvic floor disorders both in private and governmental health institutions. Even if, different single studies have been tried to identify the types and levels of pelvic floor disorders, there has been limited source of evidence regarding types, and burdens of POP in Ethiopia. As a result, this study helps to estimate the national burden of Pelvic organ prolapse at national level to design appropriate preventions and management modalities.

Methods

This systematic review and meta-analysis were conducted to estimate the national burden of POP and its associated factors in Ethiopia using the standard PRISMA checklist guideline.

Searching strategy

International databases (MEDLINE/Pub Med, Hinari, Scopus, Google scholar, African journals and literatures) were searched and included in this study. Searching terms were used using PICO formulating questions. The following Searching terms were used: pelvic floor disorders, POP, utero-vaginal prolapse, vault prolapse, rectocele, cystocele AND Ethiopia and related terms.

Eligibility criteria

Inclusion criteria

Study design

Observational studies (cross-sectional, cohort and case-control) were included.

Study area

Only studies conducted in Ethiopia without time limiting and reported the prevalence or at least one least adjusted associated factor of pelvic organ prolapse were included.

Publication status and language

Only English language articles both published and unpublished reported studies were included.

Exclusion criteria

Articles without full abstracts or texts and articles reported out of the outcome interest were excluded.

Quality assessment

After collecting the findings from all databases, the articles were exported to Microsoft Excel spreadsheet. Two authors (GG & AD) independently extracted the data and reviewed the screened and eligible articles. Any disagreement was handled by the two reviewers (GG & AD). Finally, a consensus was reached between two authors through discussion. The methodological quality of each study (sampling strategy, response rate, and representativeness of the study), comparability and outcome were checked using the NOS tool. Newcastle-Ottawa Quality Assessment Scale (NOS) for cross sectional and case control studies were used to assess the methodological quality of a study and to determine the extent to which a study has addressed the possibility of bias in its design, conduct and analysis. All of the included articles scored (NOS) 7 and more can be considered as “good” study with low risk (Table S1).

Measurement of outcome

In this study measurement of outcome was measured and included from studies report POP depending on either POP-Q stage or the traditional classification of POP.

POP-Q stage

Stage-0 “no prolapse” Stage I is when the most distal portion (leading surface) of the prolapse is 1 cm above the level of the hymen (,-1 cm) Stage II is when the most distal portion (leading edge) of the prolapse is #1 cm proximal to or extends 1 cm through the plane of hymen ($-1 cm, but # + 1 cm) Stage III is when the most distal portion of the prolapse is .1 cm below hymen but no further than 2 cm less than the TVL (there is no complete vaginal eversion) Stage IV is when there is complete eversion of the total length of the pelvic organ, meaning the pelvic organ protrudes at least the total vaginal length minus 2 cm beyond the hymen.

Traditional classification of POP

1st: Descent within the vagina 2nd: Descent to the introitus 3rd: Descent outside the introitus

Pelvic organ prolapse

Any pelvic disorder at least reported any of one of the pelvic floor disorders (utero-vaginal prolapse, rectocele, cystecole, vault prolapse) with any stages were considered as the primary outcome of the study.

Anterior compartment prolapse (cystocele)

Hernia of anterior vaginal wall often associated with descent of the bladder.

Posterior compartment prolapse (rectocele)

Hernia of the posterior vaginal segment often associated with descent of the rectum.

Apical compartment prolapse (uterine prolapse, vaginal vault prolapse)

Descent of the apex of the vagina into the lower vagina, to the hymen, or beyond the vaginal introitus.

Data extraction

Micro-soft Excel (2016), and STATA version 11 software were used for data entry and analysis respectively. Two authors (AD and GG) independently extracted all the important data using a standardized JBI data extraction format. Substantial agreement between reviewers i.e. Cohen’s kappa coefficient > 0.60 were accepted. Any disagreement between reviewers was resolved through discussion and then consensus was reached. During data extraction; name of the author, sample size, publication year, study design, prevalence, response rate, population outcome, study site, and different contributing factors were included. Moreover, prevalence of pelvic organ prolapse with 95%CI and associated factors were collected [17].

Data analysis

Egger’s regression test and funnel plot were computed to check the publication bias across and within the studies. Cochrane Q-test and I-squared statistic were used to check the heterogeneity of studies [18]. Pooled analysis was computed using a weighted inverse variance random-effects model [19]. Subgroup analysis was done by study setting, study region and year of publication. The data were analyzed and presented using STATA version 11 statistical software and forest plot respectively. The pooled prevalence of POP was expressed with 95%Cl, where as a log odds ratio was used to declare the association between associated factors and POP [17].

Results

Characteristics of the included studies

238 articles were retrieved using a search strategy about pelvic organ prolapse and associated factors in Ethiopia using online international datasets such as; MEDLINE/PubMed, Hinari, Scopus, Google scholar, African journals and literatures. After duplicates were removed, 117 studies remained. 68 articles were excluded after review of their titles and abstracts from the remaining 117 articles. Therefore, 49 full-text articles were accessed and assessed for inclusion criteria, resulting further exclusion of 40 articles primarily due to reasons (Fig. 1). As a result, 9 studies were fulfilled the inclusion criteria to undergo the final systematic review and meta-analysis (Table 1).
Fig. 1

Flow chart of selection for systematic review and meta-analysis on the burden of POP in Ethiopia

Table 1

Study characteristics included in the systematic review and meta-analysis on the burden of POP in Ethiopia

AuthorsRegionStudy settingStudy designSample sizePrevalenceQuality
Tsegay B [20]TigrayFacility basedCross-sectional370NALow risk
Asresie et al. [21]AmharaFacility basedCase control167642.3Low risk
Andualem Henok [22]SNNPRFacility basedCross-sectional42213.27Low risk
Berihun et al. [23]Amharacommunity basedCross-sectional39511.9Low risk
Dheresa et al. [24]OromiaCommunity basedCross-sectional343220.5Low risk
Menur A. et al [25]OromiaFacility basedCross-sectional12940.7Low risk
Lukman [26]AAFacility basedCross-sectional19517.2Low risk
Lukman [26]AmharaFacility basedCross-sectional15619.9Low risk
Zinash et al. [27]SNNPRFacility basedCase control318NALow risk
Flow chart of selection for systematic review and meta-analysis on the burden of POP in Ethiopia Study characteristics included in the systematic review and meta-analysis on the burden of POP in Ethiopia

Magnitude of pelvic organ prolapse in Ethiopia

The overall burden of pelvic organ prolapse is presented with a forest plot (Fig. 2). Therefore, the national estimated prevalence of pelvic organ prolapse in Ethiopia was 23.52% (95% CI: 14.3–32.74; I2 = 98.4%, P < 0.001).
Fig. 2

Pooled prevalence of pelvic organ prolapse in Ethiopia

Pooled prevalence of pelvic organ prolapse in Ethiopia

Publication bias

Funnel plot was assessed for asymmetry distribution of pelvic organ prolapse by visual inspection (Fig. 3). Egger’s regression test showed a p-value of 0.967 with no evidence of publication bias.
Fig. 3

Funnel plot showed publication bias for pelvic organ prolapse

Funnel plot showed publication bias for pelvic organ prolapse

Subgroup analysis

Subgroup analysis was employed with the evidence of heterogeneity. In this study, the Cochrane I2 statistic was 98.4%, P < 0.001, which showed the evidence of marked heterogeneity. Therefore subgroup analysis was done using study region and study design. As a result, the burden of pelvic organ prolapse was highest in Northern part of Ethiopia 99.2% whereas 88.7% in the study conducted with facility based setting (Table 2).
Table 2

Subgroup analyses on the burden of pelvic organ prolapse in Ethiopia, 2019)

VariablesSubgroupNo. of studiesPrevalence (95%CI)I2 (%)P-value
Sample designFacility based516.45 (12.12–20.78)88.7< 0.001
community based242.18 (39.91–44.46)0< 0.722
Study areaSouth East Ethiopiaa214.66 (11.02–18.31)340.218
Oromia230.15 (10.39–49.92)95.3< 0.001
Northern Ethiopiab324.75 (2.67–46.83)99.2< 0.001

a Addis Ababa & South nations nationalities and people, b Amhara & Tigray

Subgroup analyses on the burden of pelvic organ prolapse in Ethiopia, 2019) a Addis Ababa & South nations nationalities and people, b Amhara & Tigray

Factors associated with pelvic organ prolapse in Ethiopia

In this study, having body mass index (BMI) < 18.5, being rural resident and having age of the women > 40 years were the determinants factors of pelvic organ prolapse. The odds of having pelvic organ prolapse were (AOR = 3.29; 95% CI: 1.38–7.85), I2 = 47.5%, P = 0.167) 3.29 times prevalent among women who resided in rural areas than those who were living in urban areas (Fig. 4).
Fig. 4

The association between resident and pelvic organ prolapse

The association between resident and pelvic organ prolapse The odds of having pelvic organ prolapse were 7.43 (AOR = 7.43; 95% CI: 2.27–24.29), I2 = 75.9%, P = 0.016) times more likely among women having more than 40 years old than the younger population (Fig. 5).
Fig. 5

The association between Age and pelvic organ prolapse

The association between Age and pelvic organ prolapse The chance of having pelvic organ prolapse were (AOR = 2.59; 95% CI: 1.53–4.4), I2 = 59.9%, P = 0.64), 2.59 times more likely among women who have less than 18.5 body mass index than the counterparts (Fig. 6).
Fig. 6

The association between BMI and pelvic organ prolapse

The association between BMI and pelvic organ prolapse

Discussion

In this meta-analysis, the national magnitude of pelvic organ prolpase in Ethiopia was 23.52% (95% CI: 14.3–32.74; I2 = 98.4%, P < 0.001). The finding of this study is consistent with the study done in China [28], accounts 2962 out of 20,008 women, estimated as 14.8%. This might be due to both of our study and the study conducted at China were involving large sample size as a result, increasing the sample size may increase the precision and the accuracy of the data. The finding of this study is lower than the study done in Tanzania [29], and Gambia [30]. This highest magnitude might be justified as studies used different outcome measurements; such as, different methods of POP classification, inclusion of different age groups, and considering rural and urban resided women with different cultures and perceptions. Besides, this might be due to this systematic review and meta-analysis included studies done on nearly all institutional settings, as a result the tendency to face the burden in urban areas may be lower due to the availability and accessibility of health sectors, health professionals and mass media as a result the knowledge towards pelvic organ prolpase in the urban population may increase which leads to early detection of the problem and overcome the problem in urban resident populations, as a result the magnitude of POP is lower among women living in urban areas. The prevalence of POP in this study is higher than the study done in Nepal [31], Nigeria [32], Ghana [33], and rural Pakistan [34]. This might be due to that this study constitutes the pooled result of different community and institutional based research findings. Furthermore, in comparison with western countries the magnitude of POP in this systematic review and meta-analysis study was higher than reported magnitude among African American women. A study done in US the prevalence of POP was lower in African American women 1.9% as compared to white women 2.8% and Hispanic women 5.1% [29]. In this study, women residing in rural area (AOR = 3.29; 95% CI: 1.38–7.85) were 3.56 times more likely to have POP than the women living in urban areas. This might be justified by the burden of POP in African’s people living in United States of America and those residing in Africa comparatively higher number of home deliveries, difficult access to skilled delivery attendance, low attendance of institutional deliveries, lack of awareness on important risk factors, low coverage of family planning, lack of antenatal care follow up, lack of adequate postnatal care follow up with preventive measures, and heavier physical work load among people residing in living Africa predominantly in sub-Saharan Africa [4]. Age > 40 years (AOR = 7.43; 95% CI: 2.27–24.29) is the determinant factor to increase the risk of pelvic organ prolapse. This study finding is consistent with the study done in [35-37]. This might be due to the fact that the risk of POP increases with age because of due to pelvic muscle; ligaments and different pelvic structures are weakening as the age is increasing. As a result of advanced age, the physiological presenation of menopausal women are clearly seen. For example, kyphotic changes due to osteoporosis that developed secondary to advanced age and estrogen deficiency causes a horizontal shift in the pelvic brim which results in reflection of the abdominal contents to the pelvic floor and urogenital hiatus [38, 39]. Despite obesity (BMI 25 kg/m2) could increase the risk of POP, this systematic review and meta-analysis revealed a contrary finding that being underweight (BMI,18.5 kg/m2) increases the risk of POP threefold [40, 41]. On the contrary, this systematic review and meta-analysis finding showed that BMI ≤ 18 kg/m2 (AOR = 2.59; 95% CI: 1.53–4.4) is increasing the burden of pelvic organ prolapse. While weight gain is a risk factor for developing prolapse, weight loss does not come into sight to be significantly associated with the waning of POP, suggesting that damage to the pelvic floor related to weight gain might be irreversible [42]. Even though the original studies reported, high parity is one of the predictors of POP, estimating odds ratio is difficult since they simply reported the presence of association with chi square. However high parity (≥4) increases the risk of POP [33, 40]. This might be due to the fact that repeated pregnancy and birth damages sphincter muscles and ligaments, which sometimes never fully regain its strength and elasticity.

Conclusion

The pooled prevalence of pelvic organ prolapse was higher. Residence, age and BMI were the predictors of pelvic organ prolpase. Identifying the modified and non modified risk factors for pelvic organ prolpase is a crucial strategic way to prevent further complications and risk of operation. Additional file 1: Table S1. NOS Quality assessment tool for cross sectional and case control studies.
  33 in total

1.  An epidemiologic study of pelvic organ prolapse in postmenopausal women: a population-based sample in China.

Authors:  Z Li; T Xu; Z Li; J Gong; Q Liu; Y Wang; J Wang; Z Xia; L Zhu
Journal:  Climacteric       Date:  2018-11-19       Impact factor: 3.005

Review 2.  Pelvic organ prolapse and incontinence in developing countries: review of prevalence and risk factors.

Authors:  Godfrey J A Walker; Prasanna Gunasekera
Journal:  Int Urogynecol J       Date:  2010-07-09       Impact factor: 2.894

3.  Racial differences in pelvic organ prolapse.

Authors:  Emily L Whitcomb; Guri Rortveit; Jeanette S Brown; Jennifer M Creasman; David H Thom; Stephen K Van Den Eeden; Leslee L Subak
Journal:  Obstet Gynecol       Date:  2009-12       Impact factor: 7.661

Review 4.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.

Authors:  Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

5.  The prevalence of urinary incontinence in women in four European countries.

Authors:  S Hunskaar; G Lose; D Sykes; S Voss
Journal:  BJU Int       Date:  2004-02       Impact factor: 5.588

6.  Prevalence of symptomatic pelvic floor disorders in US women.

Authors:  Ingrid Nygaard; Matthew D Barber; Kathryn L Burgio; Kimberly Kenton; Susan Meikle; Joseph Schaffer; Cathie Spino; William E Whitehead; Jennifer Wu; Debra J Brody
Journal:  JAMA       Date:  2008-09-17       Impact factor: 56.272

7.  Screening of the pelvic organ prolapse without a physical examination; (a community based study).

Authors:  Fahimeh Ramezani Tehrani; Somayeh Hashemi; Masoumeh Simbar; Niloofar Shiva
Journal:  BMC Womens Health       Date:  2011-11-15       Impact factor: 2.809

8.  Determinants of pelvic organ prolapse among gynecologic patients in Bahir Dar, North West Ethiopia: a case-control study.

Authors:  Ayalnesh Asresie; Eleni Admassu; Tesfaye Setegn
Journal:  Int J Womens Health       Date:  2016-12-12

9.  Undue reliance on I(2) in assessing heterogeneity may mislead.

Authors:  Gerta Rücker; Guido Schwarzer; James R Carpenter; Martin Schumacher
Journal:  BMC Med Res Methodol       Date:  2008-11-27       Impact factor: 4.615

10.  Prevalence and risk factors for pelvic organ prolapse in Kilimanjaro, Tanzania: A population based study in Tanzanian rural community.

Authors:  Gileard G Masenga; Benjamin C Shayo; Vibeke Rasch
Journal:  PLoS One       Date:  2018-04-25       Impact factor: 3.240

View more
  8 in total

Review 1.  International urogynecology consultation chapter 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs.

Authors:  Heidi W Brown; Aparna Hegde; Markus Huebner; Hedwig Neels; Hayley C Barnes; Gisele Vissoci Marquini; Narmin Mukhtarova; Bernard Mbwele; Visha Tailor; Ervin Kocjancic; Elisa Trowbridge; Lynsey Hayward
Journal:  Int Urogynecol J       Date:  2022-01-03       Impact factor: 2.894

2.  One in ten ever-married women who visited health facilities for various reasons have pelvic organ prolapse in Harari regional state, Eastern Ethiopia.

Authors:  Dawit Abebe; Mohammed Abdurke Kure; Enku Afework Demssie; Sinetibeb Mesfin; Melake Demena; Merga Dheresa
Journal:  BMC Womens Health       Date:  2022-06-11       Impact factor: 2.742

3.  Gynaecologists' views on the management of Vaginal Vault Prolapse: A qualitative study.

Authors:  Omaema Al-Baghdadi; Christian Barnick; Garima Srivastava; Hassan M Elbiss
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 1.088

4.  Determinants of pelvic organ prolapse at public hospitals in Hawassa city, Southern Ethiopia, 2020: unmatched case control study.

Authors:  Bezabih Terefe Dora; Zemenu Yohannes Kassa; Nebiha Hadra; Bamlaku Birie Tsigie; Hawi Leul Esayas
Journal:  BMC Womens Health       Date:  2022-07-20       Impact factor: 2.742

5.  Risk factors of pelvic organ prolapse at Asella Teaching and Referral Hospital: Unmatched case control study.

Authors:  Mohammed Suleiman Obsa; Tahir A Worji; Nemo A Kedir; Negeso G Kute
Journal:  Front Glob Womens Health       Date:  2022-09-13

6.  Pelvic organ prolapse and associated factors among women admitted to gynecology ward at the Hiwot Fana Comprehensive Specialized Hospital, Harar, eastern Ethiopia.

Authors:  Abdek Ali; Elias Yadeta; Addis Eyeberu; Lemesa Abdisa; Miressa Bekana; Merga Dheresa
Journal:  SAGE Open Med       Date:  2022-09-22

7.  Global burden and trends of pelvic organ prolapse associated with aging women: An observational trend study from 1990 to 2019.

Authors:  Bo Wang; Yingying Chen; Xiaoran Zhu; Tian Wang; Mei Li; Yibao Huang; Liru Xue; Qingqing Zhu; Xiaofan Gao; Mingfu Wu
Journal:  Front Public Health       Date:  2022-09-15

Review 8.  Age and/or postmenopausal status as risk factors for pelvic organ prolapse development: systematic review with meta-analysis.

Authors:  Luiz Gustavo Oliveira Brito; Glaucia Miranda Varella Pereira; Pamela Moalli; Oksana Shynlova; Jittima Manonai; Adi Yehuda Weintraub; Jan Deprest; Maria Augusta T Bortolini
Journal:  Int Urogynecol J       Date:  2021-08-05       Impact factor: 1.932

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.